Charlie E. Massie

4.2k citations
8 papers · 154 indexed · h-index 6
Topics
Prostate Cancer Treatment and Research (4 papers)Epigenetics and DNA Methylation (2 papers)RNA modifications and cancer (1 paper)

In The Last Decade

Charlie E. Massie

8 papers receiving 153 citations

Peers

Charlie E. Massie
Comparison fields: 5 of 36
  • Molecular Biology 87
  • Pulmonary and Respiratory Medicine 63
  • Cancer Research 54
  • Oncology 33
  • Immunology 32
Replace David T. Hoang with:
David T. Hoang United States
Øystein Størkersen Norway
Núria Pedrola Spain
Rajni Sonavane United States
Ana Remírez Spain
Nikul Patel United States
Ingo Stehle Germany
Cody Weimholt United States
Christian Veltkamp Germany
Irene Otero Spain
Charlie E. Massie relative to David T. Hoang United States David T. Hoang's profile →
Citations per field
00.5×1.5×2.3×
David T. Hoang · 1×
Citations per year

Countries citing papers authored by Charlie E. Massie

Since Specialization
Citations

This map shows the geographic impact of Charlie E. Massie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlie E. Massie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlie E. Massie more than expected).

Fields of papers citing papers by Charlie E. Massie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlie E. Massie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlie E. Massie. The network helps show where Charlie E. Massie may publish in the future.

Co-authorship network of co-authors of Charlie E. Massie

This figure shows the co-authorship network connecting the top 25 collaborators of Charlie E. Massie. A scholar is included among the top collaborators of Charlie E. Massie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlie E. Massie. Charlie E. Massie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 5
2 68
3 28
4 28
5 15
6 4
7 1
8 5

About Charlie E. Massie

Charlie E. Massie is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Genetics, having authored 8 papers that have together received 154 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (4 papers), Epigenetics and DNA Methylation (2 papers) and RNA modifications and cancer (1 paper). The work is most often cited by research in Cancer Research (54 citations), Pulmonary and Respiratory Medicine (63 citations) and Immunology (32 citations). Charlie E. Massie has collaborated with scholars based in United Kingdom, Norway and Australia. Frequent co-authors include Vincent J. Gnanapragasam, Anne Y. Warren, Andy G. Lynch, Satoshi Hori, Nathan Richoz, Julia Jones, Brendan Berry, Tristan Barrett, Menna R. Clatworthy and Anne Babbage. Their work appears in journals such as The Lancet, British Journal of Cancer and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026